Penumbra Inc

Penumbra Inc

PEN · NYSE · Healthcare / Medical Devices

320.91USD+0.14 (+0.04%)

Price History

Full chart

Market Stats

Previous Close320.77
Open322.00
Day Range320.63 – 322.00
52-Week Range221.26 – 362.41
Volume237.58K
Market Cap12.56B
P/E (TTM)78.16
Forward P/E55.56
EPS4.08
Dividend Yield0.00%
Beta0.70
50-Day Avg321.56
200-Day Avg326.37

About

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Adam Elsesser J.D.
  • Employees4.70K
  • HeadquartersOne Penumbra Place, Alameda, CA, United States, 94502, USA
  • Websitehttps://www.penumbrainc.com

Leadership

  • Mr. Adam Elsesser J.D.Co-Founder, Chairman & CEO · b. 1962
  • Ms. Shruthi NarayanPresident · b. 1985
  • Dr. Arani Bose M.D.Co-Founder & Director · b. 1962
  • Ms. Maggie S. YuenChief Financial Officer · b. 1972
  • Mr. Lambert ShiuChief Accounting Officer · b. 1980
  • Ms. Johanna Roberts J.D.Executive VP, General Counsel & Secretary · b. 1972
  • Mr. Ben SorciExecutive Vice President of Operations
  • Ms. Jee Hamlyn-HarrisInvestor Relations Officer
  • Mr. Ben TompkinsExecutive Vice President of Development & Compliance
  • Mr. Jason Richard MillsExecutive Vice President of Strategy

Financials

Income Statement

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue73.14M88.85M125.51M186.09M263.32M333.76M444.94M547.40M560.41M747.59M847.13M1.06B1.19B1.40B
Growth (%)-+21.47%+41.26%+48.27%+41.50%+26.75%+33.31%+23.03%+2.38%+33.40%+13.32%+24.95%+12.86%+17.50%
Cost of Revenue24.18M30.97M42.67M62.04M92.49M116.62M152.41M175.44M222.24M272.21M311.93M375.88M439.62M461.23M
Gross Profit48.96M57.88M82.84M124.06M170.83M217.14M292.53M371.96M338.18M475.38M535.21M682.64M755.00M942.44M
Gross Margin66.94%65.14%66.00%66.66%64.88%65.06%65.75%67.95%60.34%63.59%63.18%64.49%63.20%67.14%
Operating Expense45.53M59.00M79.83M119.88M172.18M215.98M293.38M324.46M377.12M482.88M529.13M609.09M668.77M753.19M
Operating Income3.43M-1.13M3.01M4.18M-1.35M1.17M-852.00K47.51M-38.94M-7.50M6.08M73.55M86.22M189.25M
Operating Margin4.69%-1.27%2.40%2.25%-0.51%0.35%-0.19%8.68%-6.95%-1.00%0.72%6.95%7.22%13.48%
EBITDA3.43M-449.00K3.76M5.93M947.00K4.95M36.15M55.61M-26.05M8.91M29.96M108.65M45.99M223.91M
EBITDA Margin4.69%-0.51%3.00%3.19%0.36%1.48%8.12%10.16%-4.65%1.19%3.54%10.26%3.85%15.95%
Net Income1.96M4.10M2.25M2.37M14.81M4.66M6.60M48.46M-19.26M2.62M-2.00M90.95M14.01M177.69M
Net Income Margin2.68%4.61%1.79%1.27%5.63%1.40%1.48%8.85%-3.44%0.35%-0.24%8.59%1.17%12.66%
R&D12.55M14.08M15.57M18.03M23.88M31.66M36.16M51.72M90.05M104.55M79.41M84.42M94.78M89.77M
R&D as % of Total Revenue17.16%15.85%12.41%9.69%9.07%9.49%8.13%9.45%16.07%13.99%9.37%7.98%7.93%6.40%
Interest Expense000541.00K00012.19M17.37M16.07M1.75M1.74M1.42M1.31M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.29%0.00%0.00%0.00%2.23%3.10%2.15%0.21%0.16%0.12%0.09%

Balance Sheet

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-71.15M121.38M263.85M308.25M476.67M515.01M665.90M822.98M1.24B1.37B1.56B1.53B1.83B
Total Liabilities-79.21M133.75M31.33M41.71M76.26M92.59M180.29M185.19M290.32M372.03M377.36M382.25M398.92M
Total Equity--8.06M-12.37M232.52M266.55M400.41M422.24M485.89M641.50M953.93M998.86M1.18B1.15B1.43B
Cash-4.13M3.29M19.55M13.24M50.64M67.85M72.78M69.67M59.38M69.86M167.49M324.40M186.90M
Total Debt-6.00M-----82.30M77.28M173.55M235.77M234.34M223.39M219.70M
Net Debt-1.87M-3.29M-19.55M-13.24M-50.64M-67.85M9.52M7.61M114.17M165.91M66.86M-101.02M32.80M

Cash Flow

Currency: USD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.40M-6.39M-22.28M-12.81M12.69M28.81M26.65M-33.24M9.50M-55.66M97.33M168.48M238.66M
Investing Cash Flow-1.25M-37.00M-85.82M687.00K-77.65M-385.00K-11.91M-104.15M-21.73M54.79M-16.08M77.62M-404.59M
Financing Cash Flow2.18M42.90M124.42M7.13M104.36M-9.81M-9.76M134.92M836.00K11.62M16.20M-87.01M26.53M
Capital Expenditure798.00K3.89M5.47M13.63M15.03M9.60M22.11M24.76M21.18M19.30M15.21M21.18M63.73M
Free Cash Flow-4.19M-10.28M-27.75M-26.44M-2.34M19.20M4.54M-58.00M-11.68M-74.96M82.12M147.30M174.93M
Dividends Paid--000-18.54M10.07M15.83M8.04M---
FCF to OCF123.50%160.85%124.57%206.47%-18.45%66.67%17.05%174.47%-122.90%134.67%84.37%87.43%73.30%
Dividend Paid to FCF--0.00%0.00%0.00%-407.99%-17.36%-135.57%-10.73%---

Earnings

Report DateNov 12, 2015Mar 8, 2016May 9, 2016Aug 9, 2016Nov 3, 2016Feb 28, 2017May 9, 2017Aug 8, 2017Nov 7, 2017Feb 27, 2018May 8, 2018Aug 7, 2018Nov 5, 2018Feb 26, 2019May 7, 2019Aug 6, 2019Nov 7, 2019Feb 25, 2020May 7, 2020Aug 3, 2020Oct 28, 2020Feb 23, 2021May 4, 2021Aug 9, 2021Nov 3, 2021Feb 22, 2022May 3, 2022Aug 4, 2022Nov 3, 2022Feb 23, 2023May 2, 2023Aug 1, 2023Nov 2, 2023Feb 22, 2024May 7, 2024Jul 30, 2024Oct 30, 2024Feb 20, 2025Apr 23, 2025Jul 29, 2025Nov 5, 2025Feb 25, 2026May 6, 2026Jul 30, 2026Nov 4, 2026
EPS Estimate-0.16-0.10-0.07-0.07-0.11-0.09-0.05-0.03-0.05-0.01-0.020.030.040.120.110.220.160.190.13-0.39-0.08-0.070.090.170.170.220.04-0.030.010.150.110.280.450.700.380.560.690.890.670.820.901.101.061.151.18
EPS Actual0.030.050.020.01-0.04-0.08-0.10-0.050.010.680.060.150.170.130.230.270.250.220.04-0.300.060.420.270.210.120.10-0.010.010.010.160.230.430.670.760.410.640.850.970.830.860.971.181.010.88-
Surprise118.75%150.00%128.57%114.29%63.64%11.11%-100.00%-66.67%120.00%6900.00%400.00%400.00%325.00%8.33%109.09%22.73%56.25%15.79%-69.23%23.08%175.00%700.00%200.00%23.53%-29.41%-54.55%-125.00%133.33%0.00%6.67%109.09%53.57%48.89%8.57%7.89%14.29%23.19%8.54%23.88%4.88%7.78%7.27%-4.72%-23.48%-
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap12.56B
Enterprise Value12.14B
Trailing P/E78.16
Forward P/E55.56
PEG Ratio3.60
Price / Sales8.35
Price / Book8.22
EPS4.08
Book Value38.86
Revenue (TTM)1.50B
Gross Profit (TTM)1.02B
EBITDA204.28M
Profit Margin10.67%
Operating Margin10.52%
Return on Equity11.37%
Return on Assets6.42%
Shares Outstanding39.39M
Shares Float38.27M
Beta0.70
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 18 analystsTarget 361.83
  • Strong Buy
    12
  • Buy
    2
  • Hold
    4

Ownership Breakdown

Institutions
88.36%
Insiders
2.90%
Retail / Other
8.74%

Top Institutional Holders

  • BlackRock Inc
    4.33M10.99%
  • HBK INVESTMENTS L P
    1.84M4.67%
  • Vanguard Capital Management, LLC
    1.69M4.30%
  • Vanguard Portfolio Management, LLC
    1.65M4.20%
  • State Street Corp
    1.19M3.01%
  • Geode Capital Management, LLC
    795.45K2.02%
  • Balyasny Asset Management LLC
    762.10K1.93%
  • NORGES BANK
    752.24K1.91%
  • The Goldman Sachs Group Inc
    720.58K1.83%
  • Millennium Management LLC
    700.61K1.78%
  • Citigroup Inc
    620.94K1.58%
  • UBS Group AG
    560.34K1.42%
  • Amvescap Plc.
    538.20K1.37%
  • FMR Inc
    496.11K1.26%
  • Capital World Investors
    479.70K1.22%

Top Fund Holders

  • iShares Core S&P Mid-Cap ETF
    1.38M3.50%
  • Vanguard MStar Total Stk Mkt Idx Invest
    1.19M3.01%
  • Vanguard Small Cap Index
    859.42K2.18%
  • BlackRock Event Driven Equity Instl
    769.79K1.95%
  • Vanguard MStar Small Cap Growth Indx Inv
    493.39K1.25%

Stock Splits

  • Nov 16, 20141:10